Kelsey Stephen Michael: insider trades.
Kelsey Stephen Michael reported 12 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 10 sales ($19.8M), across 1 company.
- Transactions
- 12
- Purchases (P)
- 0
- Sales (S)
- 10
- Companies
- 1
- Name as filed
- Kelsey Stephen Michael
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Revolution Medicines, Inc. (RVMD) | Officer · See Remarks | 12 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-16 | Revolution Medicines, Inc. | S | 85 | $195.01 | 291,791 | Form 4 |
| 2026-09-16 | Revolution Medicines, Inc. | S | 5,484 | $199.3 | 286,307 | Form 4 |
| 2026-09-11 | Revolution Medicines, Inc. | S | 3,270 | $205.81 | 291,876 | Form 4 |
| 2026-09-11 | Revolution Medicines, Inc. | S | 4,995 | $204.84 | 295,146 | Form 4 |
| 2026-09-11 | Revolution Medicines, Inc. | S | 17,949 | $203.87 | 300,141 | Form 4 |
| 2026-09-11 | Revolution Medicines, Inc. | S | 18,869 | $203.06 | 318,090 | Form 4 |
| 2026-09-11 | Revolution Medicines, Inc. | S | 21,447 | $201.75 | 336,959 | Form 4 |
| 2026-09-11 | Revolution Medicines, Inc. | S | 13,368 | $200.78 | 358,406 | Form 4 |
| 2026-09-11 | Revolution Medicines, Inc. | S | 11,833 | $200.11 | 371,774 | Form 4 |
| 2026-09-11 | Revolution Medicines, Inc. | S | 800 | $198.55 | 383,607 | Form 4 |
| 2026-09-11 | Revolution Medicines, Inc. | M | 52,500 | $42.45 | 344,376 | Form 4 |
| 2026-09-11 | Revolution Medicines, Inc. | M | 40,031 | $40.74 | 384,407 | Form 4 |
Questions
What stock did Kelsey Stephen Michael buy or sell?
Kelsey Stephen Michael reported 12 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 10 sales ($19.8M), across 1 company.
Is Kelsey Stephen Michael the same person as other filers with this name?
This page covers SEC CIK 1462808 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/kelsey-stephen-michael-1462808.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.